In OncoLand, each sample can be grouped by extensive metadata, including clinical metadata such as clinical calls of receptor expression by immunohistochemistry. You can quickly partition a gene's expression by each permutation of multiple clinical variables to identify combinations (such as triple-negative breast cancer samples) that are significantly different.